Annual Operating Profit
-$223.05 M
-$450.12 M-198.23%
December 31, 2023
Summary
- As of February 7, 2025, ABCL annual operating income is -$223.05 million, with the most recent change of -$450.12 million (-198.23%) on December 31, 2023.
- During the last 3 years, ABCL annual operating profit has fallen by -$387.40 million (-235.72%).
- ABCL annual operating profit is now -198.23% below its all-time high of $227.06 million, reached on December 31, 2022.
Performance
ABCL Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$90.17 M
-$28.00 K-0.03%
September 30, 2024
Summary
- As of February 7, 2025, ABCL quarterly operating income is -$90.17 million, with the most recent change of -$28.00 thousand (-0.03%) on September 30, 2024.
- Over the past year, ABCL quarterly operating profit has dropped by -$28.00 thousand (-0.03%).
- ABCL quarterly operating profit is now -139.18% below its all-time high of $230.14 million, reached on March 31, 2022.
Performance
ABCL Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$294.61 M
-$38.11 M-14.86%
September 30, 2024
Summary
- As of February 7, 2025, ABCL TTM operating income is -$294.61 million, with the most recent change of -$38.11 million (-14.86%) on September 30, 2024.
- Over the past year, ABCL TTM operating profit has dropped by -$38.11 million (-14.86%).
- ABCL TTM operating profit is now -184.17% below its all-time high of $350.03 million, reached on September 30, 2022.
Performance
ABCL TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
ABCL Operating Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -198.2% | -0.0% | -14.9% |
3 y3 years | -235.7% | -280.2% | -200.2% |
5 y5 years | -10000.0% | -6156.7% | -10000.0% |
ABCL Operating Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -198.2% | at low | -139.2% | at low | -184.2% | at low |
5 y | 5-year | -198.2% | at low | -139.2% | at low | -184.2% | at low |
alltime | all time | -198.2% | at low | -139.2% | at low | -184.2% | at low |
AbCellera Biologics Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$90.17 M(+0.0%) | -$294.61 M(+14.9%) |
Jun 2024 | - | -$90.14 M(+74.6%) | -$256.50 M(+20.3%) |
Mar 2024 | - | -$51.62 M(-17.6%) | -$213.17 M(-4.4%) |
Dec 2023 | -$223.05 M(-198.2%) | -$62.68 M(+20.4%) | -$223.05 M(+13.5%) |
Sep 2023 | - | -$52.06 M(+11.2%) | -$196.48 M(+88.0%) |
Jun 2023 | - | -$46.81 M(-23.9%) | -$104.53 M(+61.9%) |
Mar 2023 | - | -$61.50 M(+70.3%) | -$64.58 M(-128.4%) |
Dec 2022 | $227.06 M | -$36.10 M(-190.5%) | $227.06 M(-35.1%) |
Sep 2022 | - | $39.88 M(-681.3%) | $350.03 M(+22.2%) |
Jun 2022 | - | -$6.86 M(-103.0%) | $286.43 M(-1.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | $230.14 M(+164.9%) | $290.91 M(+31.0%) |
Dec 2021 | $221.90 M(+35.0%) | $86.86 M(-466.3%) | $221.98 M(-24.5%) |
Sep 2021 | - | -$23.72 M(+893.5%) | $294.00 M(-7.3%) |
Jun 2021 | - | -$2.39 M(-101.5%) | $317.28 M(-2.9%) |
Mar 2021 | - | $161.22 M(+1.5%) | $326.67 M(+98.8%) |
Dec 2020 | $164.35 M(-7114.6%) | $158.88 M(<-9900.0%) | $164.35 M(+3976.4%) |
Sep 2020 | - | -$431.00 K(-106.2%) | $4.03 M(-9.7%) |
Jun 2020 | - | $7.00 M(-740.7%) | $4.46 M(-276.2%) |
Mar 2020 | - | -$1.09 M(-24.2%) | -$2.53 M(+75.8%) |
Dec 2019 | -$2.34 M(-378.6%) | -$1.44 M | -$1.44 M |
Dec 2018 | $841.00 K | - | - |
FAQ
- What is AbCellera Biologics annual operating income?
- What is the all time high annual operating profit for AbCellera Biologics?
- What is AbCellera Biologics annual operating profit year-on-year change?
- What is AbCellera Biologics quarterly operating income?
- What is the all time high quarterly operating profit for AbCellera Biologics?
- What is AbCellera Biologics quarterly operating profit year-on-year change?
- What is AbCellera Biologics TTM operating income?
- What is the all time high TTM operating profit for AbCellera Biologics?
- What is AbCellera Biologics TTM operating profit year-on-year change?
What is AbCellera Biologics annual operating income?
The current annual operating profit of ABCL is -$223.05 M
What is the all time high annual operating profit for AbCellera Biologics?
AbCellera Biologics all-time high annual operating income is $227.06 M
What is AbCellera Biologics annual operating profit year-on-year change?
Over the past year, ABCL annual operating income has changed by -$450.12 M (-198.23%)
What is AbCellera Biologics quarterly operating income?
The current quarterly operating profit of ABCL is -$90.17 M
What is the all time high quarterly operating profit for AbCellera Biologics?
AbCellera Biologics all-time high quarterly operating income is $230.14 M
What is AbCellera Biologics quarterly operating profit year-on-year change?
Over the past year, ABCL quarterly operating income has changed by -$28.00 K (-0.03%)
What is AbCellera Biologics TTM operating income?
The current TTM operating profit of ABCL is -$294.61 M
What is the all time high TTM operating profit for AbCellera Biologics?
AbCellera Biologics all-time high TTM operating income is $350.03 M
What is AbCellera Biologics TTM operating profit year-on-year change?
Over the past year, ABCL TTM operating income has changed by -$38.11 M (-14.86%)